This inventor holds 1 USPTO granted patent. Top assignee: Wayne State University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Rybak: Innovator in Drug Delivery Systems
Introduction
Michael Rybak is a prominent inventor based in Detroit, MI (US). He has made significant contributions to the field of drug delivery systems, particularly in the treatment of infections. His innovative work focuses on lipid-based drug delivery vehicles that enhance the efficacy of antibiotics.
Latest Patents
Michael Rybak holds a patent for drug delivery systems aimed at treating infections. His patent, titled "Lipid-based drug delivery vehicles," describes the use of liposomal nanoparticles that include antibiotics for the treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) infections. These drug delivery vehicles are designed to have high drug-loading capabilities, avoid accumulation in the liver, and can optionally incorporate one or more targeting ligands. He has 1 patent to his name.
Career Highlights
Michael Rybak is affiliated with Wayne State University, where he continues to advance research in drug delivery systems. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from serious infections.
Collaborations
Some of his notable coworkers include Arun K Iyer and Samaresh Sau, who have collaborated with him on various research projects.
Conclusion
Michael Rybak's contributions to drug delivery systems represent a significant advancement in the treatment of infections. His innovative approach and dedication to research continue to impact the field positively.